DaVita HealthCare Partners IncGrowing patient population and shift to home dialysis increase demand for DaVita's services.
The global peritoneal dialysis market is forecast to grow from US$ 11.56 billion in 2025 to US$ 21.55 billion by 2034, a compound annual growth rate of 7.4 percent, according to a new report by The Insight Partners. North America leads the market, supported by advanced renal care infrastructure and established reimbursement frameworks, while Asia Pacific is expected to offer strong growth potential due to rising chronic kidney disease volumes and expanding healthcare infrastructure. The product segment dominates by offerings, driven by recurring demand for dialysate solutions, bags, catheters, and cyclers, and automated peritoneal dialysis is the fastest-growing dialysis type as patients prefer overnight treatment and remote monitoring. Homecare settings are becoming increasingly important as healthcare systems promote home dialysis to ease in-center capacity constraints, with Vantive reporting that approximately 4 million people worldwide receive dialysis for chronic kidney disease. Recent industry developments include Fresenius Medical Care’s global launch of the Kinexus digital platform in June 2026 and Vantive’s introduction of the HomeAdvantage home therapy ecosystem in November 2025.
DaVita HealthCare Partners IncGrowing patient population and shift to home dialysis increase demand for DaVita's services.
Fresenius Medical Care AG & Co. KGaAMarket growth and home dialysis trend benefit Fresenius Medical Care's peritoneal dialysis products.
Vantive is a key player in the expanding peritoneal dialysis market.